A Calgary-based drug maker successfully posted promising Phase 1 trial results for its own COVID-19 vaccine, but the company’s future endeavours in Canada remain a question mark without federal funding for manufacturing.
A Calgary-based drug maker successfully posted promising Phase 1 trial results for its own COVID-19 vaccine, but the company’s future endeavours in Canada remain a question mark without federal funding for manufacturing.